Clinical Trials List
2025-03-01 - 2027-02-28
Phase II
Recruiting2
ICD-10C47.0
Malignant neoplasm of peripheral nerves of head, face and neck
ICD-10C49.0
Malignant neoplasm of connective and soft tissue of head, face and neck
ICD-10Z51.12
Encounter for antineoplastic immunotherapy
ICD-9171.0
Malignant neoplasm of connective and other soft tissue of head, face and neck
-
Sponsor
-
Trial scale
Taiwan Multiple Center
-
Update
2026/02/01
Investigators and Locations
Co-Principal Investigator
- 廖志穎 Division of Radiation Therapy
- 黃繼賢 Division of Radiation Therapy
- 周發揚 Division of Neurology
- Yu-Cheng Kuo Division of Radiation Therapy
- Yao-Ching Wang Division of Radiation Therapy
- Ching Yun Hsieh Division of Hematology & Oncology
- Ying-Chun Lin Division of Radiation Therapy
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 朱本元 Division of Otolaryngology
- Muh-Hwa Yang Division of Hematology & Oncology
- 戴世光 Division of Otolaryngology
- 吳政憲 Division of Oral and Maxillofacial Surgery
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
24 participants
-
Global
0 participants
